Advanced search
Publication Cover
The European Journal of Contraception & Reproductive Health Care Volume 20, 2015 - Issue 1
Submit an article Journal homepage
591
Views
23
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH ARTICLE

Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use

Waleska ModestoHuman Reproduction Unit, Department of Obstetrics and Gynaecology, School of Medical Sciences and the National Institute of Hormones and Women's Health, University of Campinas (UNICAMP), Campinas, SP, Brazil
,
Priscila de Nazaré Silva dos SantosHuman Reproduction Unit, Department of Obstetrics and Gynaecology, School of Medical Sciences and the National Institute of Hormones and Women's Health, University of Campinas (UNICAMP), Campinas, SP, Brazil
,
Vinicius Machado CorreiaHuman Reproduction Unit, Department of Obstetrics and Gynaecology, School of Medical Sciences and the National Institute of Hormones and Women's Health, University of Campinas (UNICAMP), Campinas, SP, Brazil
,
Luiza BorgesHuman Reproduction Unit, Department of Obstetrics and Gynaecology, School of Medical Sciences and the National Institute of Hormones and Women's Health, University of Campinas (UNICAMP), Campinas, SP, Brazil
&
Luis BahamondesHuman Reproduction Unit, Department of Obstetrics and Gynaecology, School of Medical Sciences and the National Institute of Hormones and Women's Health, University of Campinas (UNICAMP), Campinas, SP, BrazilCorrespondence[email protected]
Pages 57-63 | Published online: 27 Aug 2014

REFERENCES

  • Caballero B. The global epidemic of obesity: An overview. Epidemiol Rev 2007;29:1–5.
  • May AM, Romaguera D, Travier N, et al. Combined impact of lifestyle factors on prospective change in body weight and waist circumference in participants of the EPIC-PANACEA study. PLoS One 2012;7:e50712.
  • Lopez LM, Edelman A, Chen M, et al. Progestin-only contraceptives: Effects on weight. Cochrane Database Syst Rev 2013;2:7.
  • Le YC, Rahman M, Berenson AB. Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users. Obstet Gynecol 2009;114: 279–84.
  • Said S, Omar K, Koetsawang S, et al. A multicentred phase III comparative trial of depo-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg. 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation. Special Programme of Research, Development and Research Training in Human Reproduction. Contraception 1986; 34:223–35.
  • Vickery Z, Madden T, Zhao Q, et al. Weight change at 12 months in users of three progestin-only contraceptive methods. Contraception 2013; 88:503–8.
  • Nault AM, Peipert JF, Zhao Q, et al. Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate. Am J Obstet Gynecol 2013;208:1–8.
  • Hassan DF, Petta CA, Aldrighi JM, et al. Weight variation in a cohort of women using copper IUD for contraception. Contraception 2003;68:27–30.
  • Bahamondes L, Castillo S Del Tabares G, et al. Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years. Contraception 2001;64:223–25.
  • Yela DA, Monteiro IM, Bahamondes LG, et al. Weight variation in users of the levonorgestrel-releasing intrauterine system, of the copper IUD and of medroxyprogesterone acetate in Brazil. Rev Assoc Med Bras 2006;521:32–36.
  • Pantoja M, Medeiros T, Baccarin MC, et al. Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive. Contraception 2010;81: 107–11.
  • Baldaszti E, Wimmer-Puchinger B, Löschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception 2003;67:87–91.
  • Sheng J, Zhang WY, Zhang JP, et al. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception 2009;79: 189–193.
  • Peipert JF, Zhao Q, Allsworth JE, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol 2011;117:1105–13.
  • Suhonen S, Haukkamaa M, Jakobsson T, et al. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: A comparative study. Contraception 2004;69:407–12.
  • Dal’ Ava N, Bahamondes L, Bahamondes MV, et al. Body weight and composition in users of levonorgestrel-releasing intrauterine system. Contraception 2012; 86:350–3.
  • Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med 2012;366:1998–2007.
  • Clark MK, Dillon JS, Sowers M, et al. Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception. Int J Obes (Lond) 2005;29:1252–8.
  • Berenson AB, Rahman M. Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use. Am J Obstet Gynecol 2009;200:329. e1–8.
  • Modesto W, Bahamondes MV, Silva Dos Santos P, et al. Exploratory study of the effect of lifestyle counselling on bone mineral density and body composition in users of the contraceptive depot-medroxyprogesterone acetate. Eur J Contracept Reprod Health Care 2014;19:244–9.
  • Ministério da Saúde, Secretaria de Vigilância em Saúde: Vigitel Brasil 2011: Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico. (Série G. Estatística e Informação em Saúde). Brasília, 2012.
  • Rennie KL, Jebb SA. Prevalence of obesity in Great Britain. Obes Rev 2005;6:11–2.
  • NCHS 2012. Prevalence of obesity in the United States, 2009–2010. National Health and Nutrition Examination Survey (NCHS) Data Brief. No 82, NCHS, 2012.
  • Pelkman C. Hormones and weight change. J Reprod Med 2002; 47:791–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.